rs10521330

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000682050.1(SLC6A2):​n.*4449A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.182 in 152,176 control chromosomes in the GnomAD database, including 2,708 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2708 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

SLC6A2
ENST00000682050.1 non_coding_transcript_exon

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.97

Publications

4 publications found
Variant links:
Genes affected
SLC6A2 (HGNC:11048): (solute carrier family 6 member 2) This gene encodes a member of the sodium:neurotransmitter symporter family. This member is a multi-pass membrane protein, which is responsible for reuptake of norepinephrine into presynaptic nerve terminals and is a regulator of norepinephrine homeostasis. Mutations in this gene cause orthostatic intolerance, a syndrome characterized by lightheadedness, fatigue, altered mentation and syncope. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
SLC6A2 Gene-Disease associations (from GenCC):
  • postural orthostatic tachycardia syndrome
    Inheritance: Unknown, AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000682050.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.246 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000682050.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC6A2
NM_001172501.3
MANE Select
c.*3896A>G
downstream_gene
N/ANP_001165972.1P23975-1
SLC6A2
NM_001172504.1
c.*970A>G
downstream_gene
N/ANP_001165975.1P23975-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000278928
ENST00000624017.1
TSL:6
n.2124A>G
non_coding_transcript_exon
Exon 1 of 1
SLC6A2
ENST00000682050.1
n.*4449A>G
non_coding_transcript_exon
Exon 13 of 13ENSP00000508367.1A0A804HLI4
SLC6A2
ENST00000682050.1
n.*4449A>G
3_prime_UTR
Exon 13 of 13ENSP00000508367.1A0A804HLI4

Frequencies

GnomAD3 genomes
AF:
0.182
AC:
27706
AN:
152058
Hom.:
2702
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.250
Gnomad AMI
AF:
0.234
Gnomad AMR
AF:
0.124
Gnomad ASJ
AF:
0.160
Gnomad EAS
AF:
0.0308
Gnomad SAS
AF:
0.200
Gnomad FIN
AF:
0.194
Gnomad MID
AF:
0.196
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.182
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.182
AC:
27747
AN:
152176
Hom.:
2708
Cov.:
32
AF XY:
0.183
AC XY:
13580
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.250
AC:
10384
AN:
41502
American (AMR)
AF:
0.124
AC:
1891
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.160
AC:
554
AN:
3468
East Asian (EAS)
AF:
0.0309
AC:
160
AN:
5180
South Asian (SAS)
AF:
0.201
AC:
972
AN:
4826
European-Finnish (FIN)
AF:
0.194
AC:
2049
AN:
10588
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11086
AN:
67998
Other (OTH)
AF:
0.180
AC:
381
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1155
2310
3466
4621
5776
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.158
Hom.:
2991
Bravo
AF:
0.182

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.067
DANN
Benign
0.65
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10521330;
hg19: chr16-55740154;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.